ELEVANCE HEALTH INC (ELV)
US0367521038 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 138.639B 13.76% | 156.595B 12.95% | 171.34B 9.42% | 177.057B 3.34% | 190.558B 7.63% | 204.805B 7.48% | 224.809B 9.77% | N/A | N/A | N/A | N/A | N/A | |
| EBITDA YoY % growth | 10.457B 17.96% | 10.165B -2.79% | 11.242B 10.60% | 11.571B 2.93% | 11.959B 3.35% | 13.649B 14.13% | 15.149B 10.99% | 16.044B 5.91% | 16.836B 4.94% | 17.704B 5.16% | 18.669B 5.45% | 19.623B 5.11% | |
| EBIT YoY % growth | 9.155B 18.73% | 8.49B -7.26% | 9.497B 11.86% | 10.537B 10.95% | 11.099B 5.33% | 12.484B 12.48% | 14.69B 17.67% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | 6.60% | 5.42% | 5.54% | 5.95% | 5.82% | 6.10% | 6.53% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 25.97 15.83% | 29.05 11.86% | 33.11 13.98% | 33.30 0.56% | 35.31 6.06% | 41.31 16.98% | 49.79 20.54% | 56.99 14.46% | 64.05 12.39% | 71.86 12.19% | 82.33 14.56% | 93.88 14.04% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 3.85 -31.50% | 10.41 -2.17% | 10.24 1.22% | 8.96 7.08% | 5.85 51.84% | 12.36 18.76% | 12.17 18.78% | 10.37 15.73% | 6.93 18.49% |
| Revenue Q2Q % growth | 45.318B 6.75% | 45.969B 8.74% | 47.26B 9.34% | 48.41B 8.25% | 48.315B 6.61% | 49.642B 7.99% | 51.075B 8.07% | 51.968B 7.35% | 51.579B 6.76% |
| EBITDA Q2Q % growth | 1.371B -54.71% | 3.411B -3.51% | 3.544B -4.01% | 2.971B 9.75% | 2.336B 70.39% | 3.457B 1.35% | 3.633B 2.51% | 3.594B 20.97% | 2.531B 8.35% |
| EBIT Q2Q % growth | 1.264B -1.40% | 3.188B -0.50% | 3.084B 1.92% | 2.82B 64.72% | 1.93B 52.69% | 3.715B 16.53% | 3.735B 21.11% | 3.311B 17.41% | 2.039B 5.65% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 8.37 -6.90% | 9.76 | -1.39 | -14.20% |
| Q2 2024 Q2Q % growth | 10.12 11.95% | 10.11 | 0.01 | 0.10% |
| Q1 2024 Q2Q % growth | 10.64 12.47% | 10.64 | 0.00 | 0.03% |
| Q4 2023 Q2Q % growth | 5.62 7.46% | 5.70 | -0.08 | -1.40% |
| Q3 2023 Q2Q % growth | 8.99 19.39% | 8.52 | 0.47 | 5.47% |
| Q2 2023 Q2Q % growth | 9.04 12.44% | 8.88 | 0.16 | 1.75% |
| Q1 2023 Q2Q % growth | 9.46 14.67% | 9.35 | 0.11 | 1.13% |
| Q4 2022 Q2Q % growth | 5.23 1.75% | 5.24 | -0.01 | -0.20% |
| Q3 2022 Q2Q % growth | 7.53 10.90% | 7.22 | 0.31 | 4.30% |
| Q2 2022 Q2Q % growth | 8.04 14.37% | 7.82 | 0.22 | 2.84% |
| Q1 2022 Q2Q % growth | 8.25 17.69% | 7.89 | 0.36 | 4.54% |
| Q4 2021 Q2Q % growth | 5.14 102.36% | 5.16 | -0.02 | -0.46% |
| Q3 2021 Q2Q % growth | 6.79 61.67% | 6.43 | 0.36 | 5.53% |
| Q2 2021 Q2Q % growth | 7.03 -23.59% | 6.40 | 0.63 | 9.93% |
| Q1 2021 Q2Q % growth | 7.01 8.18% | 6.58 | 0.43 | 6.57% |
| Q4 2020 Q2Q % growth | 2.54 -34.54% | 2.55 | -0.01 | -0.21% |
| Q3 2020 Q2Q % growth | 4.20 -13.76% | 4.19 | 0.01 | 0.15% |
| Q2 2020 Q2Q % growth | 9.20 98.28% | 8.96 | 0.24 | 2.64% |
| Q1 2020 Q2Q % growth | 6.48 7.46% | 6.54 | -0.06 | -0.94% |
| Q4 2019 Q2Q % growth | 3.88 | 3.92 | -0.04 | -1.06% |
| Q3 2019 Q2Q % growth | 4.87 | 4.87 | 0.00 | 0.03% |
| Q2 2019 Q2Q % growth | 4.64 | 4.66 | -0.02 | -0.43% |
| Q1 2019 Q2Q % growth | 6.03 | 5.87 | 0.16 | 2.68% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 44.719B 5.27% | 43.8B | 919M | 2.10% |
| Q2 2024 Q2Q % growth | 43.223B -0.36% | 43.485B | -262M | -0.60% |
| Q1 2024 Q2Q % growth | 42.273B 0.24% | 43.052B | -779M | -1.81% |
| Q4 2023 Q2Q % growth | 42.454B 6.32% | 42.466B | -12M | -0.03% |
| Q3 2023 Q2Q % growth | 42.48B 6.36% | 43.042B | -562M | -1.31% |
| Q2 2023 Q2Q % growth | 43.377B 12.28% | 41.917B | 1.46B | 3.48% |
| Q1 2023 Q2Q % growth | 42.172B 10.70% | 41.24B | 932M | 2.26% |
| Q4 2022 Q2Q % growth | 39.929B 9.15% | 40.038B | -109M | -0.27% |
| Q3 2022 Q2Q % growth | 39.939B 11.49% | 39.479B | 460M | 1.17% |
| Q2 2022 Q2Q % growth | 38.632B 14.12% | 38.51B | 122M | 0.32% |
| Q1 2022 Q2Q % growth | 38.095B 17.63% | 37.727B | 368M | 0.98% |
| Q4 2021 Q2Q % growth | 36.581B 15.18% | 36.878B | -297M | -0.81% |
| Q3 2021 Q2Q % growth | 35.822B 14.90% | 35.652B | 170M | 0.48% |
| Q2 2021 Q2Q % growth | 33.851B 15.72% | 33.536B | 315M | 0.94% |
| Q1 2021 Q2Q % growth | 32.385B 9.12% | 33.272B | -887M | -2.67% |
| Q4 2020 Q2Q % growth | 31.76B 15.81% | 31.089B | 671M | 2.16% |
| Q3 2020 Q2Q % growth | 31.176B 16.82% | 30.111B | 1.065B | 3.54% |
| Q2 2020 Q2Q % growth | 29.253B 14.84% | 29.542B | -289M | -0.98% |
| Q1 2020 Q2Q % growth | 29.678B 20.27% | 28.885B | 793M | 2.75% |
| Q4 2019 Q2Q % growth | 27.424B | 27.368B | 56M | 0.20% |
| Q3 2019 Q2Q % growth | 26.687B | 26.134B | 553M | 2.12% |
| Q2 2019 Q2Q % growth | 25.473B | 25.12B | 353M | 1.41% |
| Q1 2019 Q2Q % growth | 24.676B | 24.463B | 213M | 0.87% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -43.88% | 0% | -11.52% |
| Revenue | 0% | 3.07% | -0.01% | 1.56% |